Gill, SS, Rochon, PA, Herrmann, N., Lee, PE, Sykora, K., Gunray, N., et al. (2005) Atypical antipsychotic drugs and risk of ischemic stroke: population based retrospective cohort study. BMJ330: 445.
2.
Herrmann, N., Mamdani, M., Lanctot, KL ( 2004) Atypical antipsychotics and risk of cerebrovascular accidents . Am J Psychiatry161: 1113-1115.
3.
Kleijer, BC, van Marum, RJ, Egberts, Acg, Jansen, Paf, Knol, W., Heerdink, ER ( 2008) Risk of cerebrovascular events in elderly users of antipsychotics . J Psychopharmacology. [epub July 17, 2008 ]
4.
Leucht, S., Burkard, T., Henderson, J., Maj, M., Sartorius, N. ( 2007) Physical illness and schizophrenia: a review of the literature . Acta Psychiatr Scand116: 317-333.
5.
Miller, M. ( 2008) Management of physical health in schizophrenia: a stepping stone to treatment success. Eur Neuropsychopharm18: S121-S128.
6.
Sacchetti, E., Trifiro, G., Caputi, A., Turrina, C., Spina, E., Cricelli, C., et al. (2008) Risk of stroke with typical and atypical antipsychotics: a retrospective cohort study including unexposed subjects . J Psychopharmacology22: 39-46.
7.
Schetz, JA, Perez, E., Liu, R., Chen, S., Lee, I., Simpkins, JW ( 2007) A prototypical Sigma-1 receptor antagonist protects against brain ischemia. Brain Res1181: 1-9.
8.
Yulug, B., Yildiz, A., Güzel, O., Kilic, E., Schäbitz, WR, Kilic, E. ( 2006a) Risperidone attenuates brain damage after focal cerebral ischemia in vivo. Brain Res Bull69: 656-659.
9.
Yulug, B., Yildiz, A., Hüdaoglu, O., Kilic, E., Cam, E., Schäbitz, WR ( 2006b) Olanzapine attenuates brain damage after focal cerebral ischemia in vivo. Brain Res71: 296-300.
10.
Yulug, B., Bakar, M., Ozan, E. ( 2008) The neuroprotective effect of olanzapine. J Neuropsychiatry Clin Neurosci20: 107-108.
